The best compounds identified from the in vitro assays on EGFR (i.e.15 and 18) were also tested for their antiproliferative activity towards the H1975 NSCLC cancer cell lines expressing the double mutant, obtaining satisfactory results. This evidence concerns the gene EGFR and non-small cell lung carcinoma.